diabetes

Drug lobby sues Minnesota over insulin-pricing law
Drug lobby sues Minnesota over insulin-pricing law
Beckers Hospital Review
Minnesota
regulatory
insulin
drug pricing
diabetes
PhRMA
Flag link:
FDA urged to increase safety warnings on common diabetes drug
FDA urged to increase safety warnings on common diabetes drug
Beckers Hospital Review
Public Citizen
diabetes
citizen petitions
SGLT2 inhibitor
type 1 diabetes
Flag link:
Mylan, seeking to market Victoza generic, convinces panel to start up patent review
Mylan, seeking to market Victoza generic, convinces panel to start up patent review
Fierce Pharma
Mylan
patents
generics
Novo Nordisk
Victoza
diabetes
Flag link:
Novaremed gets FDA nod for phase 2 trial of NRD135S.E1 for PDPN
Novaremed gets FDA nod for phase 2 trial of NRD135S.E1 for PDPN
Pharmaceutical Business Review
Novaremed
FDA
clinical trials
NRD135S.E1
diabetes
painful diabetic peripheral neuropathy
Flag link:
Evoke Pharma finally lands approval for lead and only drug
Evoke Pharma finally lands approval for lead and only drug
Endpoints
Evoke Pharma
FDA
diabetic gastroparesis
diabetes
Gimoti
Flag link:
Study: Pfizer's Experimental Diabetes Drug Robustly Reduces Weight and Glucose
Study: Pfizer's Experimental Diabetes Drug Robustly Reduces Weight and Glucose
BioSpace
ADA
diabetes
Pfizer
PF-06882961
Flag link:
ADA: Merck, Pfizer's Steglatro rings up CV safety win but still lags heart-helping peers
ADA: Merck, Pfizer's Steglatro rings up CV safety win but still lags heart-helping peers
Fierce Pharma
ADA
diabetes
Merck
Pfizer
Steglatro
Flag link:
ADA: AstraZeneca's diabetes-fighter Farxiga cuts risk of fast decline in kidney function
ADA: AstraZeneca's diabetes-fighter Farxiga cuts risk of fast decline in kidney function
Fierce Pharma
AstraZeneca
Farxiga
chronic kidney disease
ADA
diabetes
Flag link:
Why MannKind Stock Crushed it Monday
Why MannKind Stock Crushed it Monday
Motley Fool
MannKind
ADA
diabetes
insulin
Afrezza
inhaled insulin
Flag link:
Abbott's Bluetooth-Enabled Glucose Monitor Finally Clears FDA Hurdle
Abbott's Bluetooth-Enabled Glucose Monitor Finally Clears FDA Hurdle
Motley Fool
Abbott Labs
FDA
blood glucose monitoring
devices
diabetes
Freestyle Libre 2
Flag link:
ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show
ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show
Fierce Pharma
ADA
diabetes
Eli Lilly
Trulicity
Novo Nordisk
Ozempic
Flag link:
ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar
ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar
Fierce Pharma
ADA
diabetes
Sanofi
Soliqua
type 2 diabetes
Flag link:
ADA: Novo Nordisk's long-lasting insulin candidate matches Lantus in phase 2
ADA: Novo Nordisk's long-lasting insulin candidate matches Lantus in phase 2
Fierce Pharma
ADA
diabetes
Novo Nordisk
insulin icodec
Sanofi
Lantus
insulin
Flag link:
Key data on Medtronic's 780G, Insulet's Horizon kick off ADA 2020
Key data on Medtronic's 780G, Insulet's Horizon kick off ADA 2020
Medtech Dive
ADA
diabetes
devices
Medtech
Insulet
Medtronic
780G
Horizon insulin delivery system
Flag link:
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
Motley Fool
FDA
Mylan
Biocon
Semglee
Sanofi
insulin
Lantus
diabetes
Flag link:
FDA Announces Five Companies Are Recalling Diabetes Drugs Over Carcinogen Concerns
FDA Announces Five Companies Are Recalling Diabetes Drugs Over Carcinogen Concerns
BioSpace
product recalls
FDA
diabetes
Apotex
Amneal
Marksans
Lupin
Teva Pharmaceutical
metformin
NDMA
Flag link:
Fractyl Seeks to Turn Diabetes On Its Ear with Revita DMR
Fractyl Seeks to Turn Diabetes On Its Ear with Revita DMR
Medical Devices and Diagnostics Industry
Fractyl Labs
diabetes
type 2 diabetes
Revita DMR
devices
Medtech
Flag link:
With $55M in new funding, Bigfoot Biomedical takes strides toward FDA submission
With $55M in new funding, Bigfoot Biomedical takes strides toward FDA submission
MedCity News
Bigfoot Biomedical
FDA
smart insulin
devices
diabetes
insulin
Flag link:
FDA asks 5 drugmakers to recall metformin products
FDA asks 5 drugmakers to recall metformin products
Beckers Hospital Review
FDA
diabetes
product recalls
NDMA
metformin
Flag link:
This Diabetes Company's Q1 Earnings Reflect the Resiliency of Its Business Model
This Diabetes Company's Q1 Earnings Reflect the Resiliency of Its Business Model
Motley Fool
Insulet
diabetes
devices
insulin pumps
earnings
Flag link:

Pages